In 2000, it was suggested to me that “Autophagy will be the wave of the future; it will become the new apoptosis.” Few people would have agreed at the time, but this statement turned out to be ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Future Microbiol. 2012;7(6):719-731.

基于本文综述，研究者认为，EVs和BEVs或能参与微生物组和免疫系统之间的复杂相互作用，从而潜在促进子宫内膜异位症的进展并调节病变微环境。 本文研究结果表明，FDA批准的药物决奈达隆能在体内抑制患者机体衍生的肿瘤异种移植模型中ESCC的生长，因此该 ...